default author photo

Lisa Jose

University of the Witwatersrand

South Africa

South Africa

  • University of the Witwatersrand

SCHOLARLY PAPERS

1

DOWNLOADS

37

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Immunogenicity through to Five Years of Age Following a Single Compared with Two Dose Primary Series Followed by a Booster Dose of 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine during Infancy: An Open-Label, Randomised, Non-Inferiority Trial

Number of pages: 18 Posted: 23 Apr 2026
Daniel Kapelus, Courtney Olwagen, Alane Izu, Heena Ranchod, Christian K. Mukendi, Eleonora A. M. L. Mutsaerts, Anthonet Koen, Lisa Jose, Gaurav Kwatra, Sian Faustini, Alex G. Richter and Shabir A. Madhi
University of the Witwatersrand, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Cancer and Genomic Sciences and University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit
Downloads 37 (1,263,436)

Abstract:

Loading...

Pneumococcal conjugate vaccine, reduced-dose schedule, non-inferiority, long-term immunogenicity, South Africa, HIV-unexposed, PCV13, PCV10